ARS Pharmaceuticals, Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q1 2020 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
ARS Pharmaceuticals, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q1 2020 to Q3 2024.
  • ARS Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $3.59M, a 37.6% increase year-over-year.
  • ARS Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $12.5M, a 7.07% increase year-over-year.
  • ARS Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $9.24M, a 58.1% increase from 2022.
  • ARS Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $5.84M, a 107% increase from 2021.
  • ARS Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $2.83M, a 7.16% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $12.5M $3.59M +$982K +37.6% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-13
Q2 2024 $11.6M $3.37M +$1.27M +60.4% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-06
Q1 2024 $10.3M $3.32M +$1.07M +47.3% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $9.24M $2.28M -$2.49M -52.2% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-21
Q3 2023 $11.7M $2.61M +$2.15M +467% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-13
Q2 2023 $9.57M $2.1M +$1.74M +489% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-06
Q1 2023 $7.83M $2.25M +$1.99M +752% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $5.84M $4.76M +$16M Oct 1, 2022 Dec 31, 2022 10-K 2024-03-21
Q3 2022 -$10.1M $460K -$4.56M -90.8% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 -$5.57M $356K -$4.37M -92.5% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 -$1.19M $264K -$4.02M -93.8% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 $2.83M -$11.2M -$13.5M -593% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-23
Q3 2021 $16.3M $5.02M +$4.83M +2528% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-02
Q2 2021 $11.5M $4.73M +$4.6M +3595% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 $6.88M $4.29M +$4.24M +9017% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 $2.64M $2.27M Oct 1, 2020 Dec 31, 2020 10-K 2022-03-31
Q3 2020 $191K Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 $128K Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 $47K Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.